patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
tafluprost
Marketedupdated 2mo agoby Thea Pharma Inc
Approvedcommunity read0 votes
all catalysts(6)
approval · 6
Feb 10, 2012
approval
ZIOPTAN (TAFLUPROST) — FDA approval
tafluprost
→
Feb 22, 2013
approval
ZIOPTAN (TAFLUPROST) — FDA approval
tafluprost
→
Aug 28, 2013
approval
ZIOPTAN (TAFLUPROST) — FDA approval
tafluprost
→
Sep 4, 2015
approval
ZIOPTAN (TAFLUPROST) — FDA approval
tafluprost
→
Sep 4, 2015
approval
ZIOPTAN (TAFLUPROST) — FDA approval
tafluprost
→
Feb 25, 2026
approval
ZIOPTAN (TAFLUPROST) — FDA approval
tafluprost
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that